126 related articles for article (PubMed ID: 30102956)
1. Abnormalities in Prefrontal Cortical Gene Expression Profiles Relevant to Schizophrenia in MK-801-Exposed C57BL/6 Mice.
Zhao J; Liu X; Huo C; Zhao T; Ye H
Neuroscience; 2018 Oct; 390():60-78. PubMed ID: 30102956
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice.
Huo C; Liu X; Zhao J; Zhao T; Huang H; Ye H
Neuropharmacology; 2018 Sep; 140():287-301. PubMed ID: 30056124
[TBL] [Abstract][Full Text] [Related]
3. Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice.
Jeon SJ; Kim E; Lee JS; Oh HK; Zhang J; Kwon Y; Jang DS; Ryu JH
Neuropharmacology; 2017 Nov; 126():168-178. PubMed ID: 28899728
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
Gomes FV; Issy AC; Ferreira FR; Viveros MP; Del Bel EA; Guimarães FS
Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25618402
[TBL] [Abstract][Full Text] [Related]
5. Phencyclidine administration during neurodevelopment alters network activity in prefrontal cortex and hippocampus in adult rats.
Kjaerby C; Hovelsø N; Dalby NO; Sotty F
J Neurophysiol; 2017 Aug; 118(2):1002-1011. PubMed ID: 28539393
[TBL] [Abstract][Full Text] [Related]
6. Postnatal Administration of Dizocilpine Inhibits Neuronal Excitability in PFC and Induces Social Deficits Detected by MiceProfiler.
Zhu D; Wang H; Wu J; Wang Q; Xu L; Zhao Y; Pang K; Shi Q; Zhao W; Zhang J; Sun J
Mol Neurobiol; 2017 Dec; 54(10):8152-8161. PubMed ID: 27896651
[TBL] [Abstract][Full Text] [Related]
7. Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior.
Zuo DY; Zhang YH; Cao Y; Wu CF; Tanaka M; Wu YL
Life Sci; 2006 Apr; 78(19):2172-8. PubMed ID: 16280137
[TBL] [Abstract][Full Text] [Related]
8. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
[TBL] [Abstract][Full Text] [Related]
9. The effect of non-competitive NMDA receptor antagonist MK-801 on neuronal activity in rodent prefrontal cortex: an animal model for cognitive symptoms of schizophrenia.
Blot K; Bai J; Otani S
J Physiol Paris; 2013 Dec; 107(6):448-51. PubMed ID: 23603055
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of MK-801-induced behavioral perseveration by typical and atypical antipsychotic pretreatment in rats.
Tuplin EW; Stocco MR; Holahan MR
Behav Neurosci; 2015 Aug; 129(4):399-411. PubMed ID: 26052791
[TBL] [Abstract][Full Text] [Related]
11. Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys.
Tsukada H; Nishiyama S; Fukumoto D; Sato K; Kakiuchi T; Domino EF
Neuropsychopharmacology; 2005 Oct; 30(10):1861-9. PubMed ID: 15841110
[TBL] [Abstract][Full Text] [Related]
12. Neonatal exposure to MK-801 reduces mRNA expression of mGlu3 receptors in the medial prefrontal cortex of adolescent rats.
Uehara T; Sumiyoshi T; Rujescu D; Genius J; Matsuoka T; Takasaki I; Itoh H; Kurachi M
Synapse; 2014 May; 68(5):202-8. PubMed ID: 24549941
[TBL] [Abstract][Full Text] [Related]
13. Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice.
Jeevakumar V; Driskill C; Paine A; Sobhanian M; Vakil H; Morris B; Ramos J; Kroener S
Behav Brain Res; 2015 Apr; 282():165-75. PubMed ID: 25591475
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia.
Gulchina Y; Xu SJ; Snyder MA; Elefant F; Gao WJ
J Neurochem; 2017 Nov; 143(3):320-333. PubMed ID: 28628228
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.
Farley S; Dumas S; El Mestikawy S; Giros B
Neuropharmacology; 2012 Jan; 62(1):503-17. PubMed ID: 21945287
[TBL] [Abstract][Full Text] [Related]
16. Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.
López-Gil X; Babot Z; Amargós-Bosch M; Suñol C; Artigas F; Adell A
Neuropsychopharmacology; 2007 Oct; 32(10):2087-97. PubMed ID: 17356574
[TBL] [Abstract][Full Text] [Related]
17. Aberrant alpha and gamma oscillations ex vivo after single application of the NMDA receptor antagonist MK-801.
Lemercier CE; Holman C; Gerevich Z
Schizophr Res; 2017 Oct; 188():118-124. PubMed ID: 28109667
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity to MK-801 in phospholipase C-β1 knockout mice reveals a specific NMDA receptor deficit.
Gray L; McOmish CE; Scarr E; Dean B; Hannan AJ
Int J Neuropsychopharmacol; 2009 Aug; 12(7):917-28. PubMed ID: 19236734
[TBL] [Abstract][Full Text] [Related]
19. Modulation of hippocampus-prefrontal cortex synaptic transmission and disruption of executive cognitive functions by MK-801.
Blot K; Kimura S; Bai J; Kemp A; Manahan-Vaughan D; Giros B; Tzavara E; Otani S
Cereb Cortex; 2015 May; 25(5):1348-61. PubMed ID: 24304584
[TBL] [Abstract][Full Text] [Related]
20. Activation of the prelimbic medial prefrontal cortex induces anxiety-like behaviors via N-Methyl-D-aspartate receptor-mediated glutamatergic neurotransmission in mice.
Saitoh A; Ohashi M; Suzuki S; Tsukagoshi M; Sugiyama A; Yamada M; Oka J; Inagaki M; Yamada M
J Neurosci Res; 2014 Aug; 92(8):1044-53. PubMed ID: 24752881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
